"The United States Food and Drug Administration (USFDA) conducted inspection at the company#39;s Ghaziabad formulation facility between August 19, 2019 to August 23, 2019. The inspection was a routine Good manufacturing practice (GMP) surveillance," Unichem said in a regulatory filing.from Moneycontrol Business News https://ift.tt/2L47Y8U
No comments:
Post a Comment